scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JAD.2011.03.042 |
P698 | PubMed publication ID | 21497910 |
P2093 | author name string | Paul J Harrison | |
Rebecca A Gittins | |||
P433 | issue | 1-2 | |
P921 | main subject | neuroglia | Q177105 |
P304 | page(s) | 328-332 | |
P577 | publication date | 2011-04-17 | |
P1433 | published in | Journal of Affective Disorders | Q15716493 |
P1476 | title | A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder | |
P478 | volume | 133 |
Q26770756 | A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue |
Q24607978 | A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide |
Q47177999 | A postmortem stereological study of the amygdala in Williams syndrome |
Q99711510 | Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role? |
Q37299355 | Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders |
Q39186841 | An astroglial basis of major depressive disorder? An overview. |
Q37604161 | Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence |
Q33843049 | Astrocyte Activation in Locus Coeruleus Is Involved in Neuropathic Pain Exacerbation Mediated by Maternal Separation and Social Isolation Stress |
Q26827833 | Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue |
Q88373251 | Astrocyte pathology in the ventral prefrontal white matter in depression |
Q64929169 | Astrocyte, a Promising Target for Mood Disorder Interventions. |
Q48027529 | Astroglia, Glutamatergic Transmission and Psychiatric Diseases |
Q33820463 | Biological substrates underpinning diagnosis of major depression |
Q52356865 | Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders. |
Q26772830 | Depression as a Glial-Based Synaptic Dysfunction |
Q36193595 | Distinction of Neurons, Glia and Endothelial Cells in the Cerebral Cortex: An Algorithm Based on Cytological Features |
Q92370918 | Evidence of decreased gap junction coupling between astrocytes and oligodendrocytes in the anterior cingulate cortex of depressed suicides |
Q48378631 | Fibrillary astrocytes are decreased in the subgenual cingulate in schizophrenia |
Q37740652 | From Engrams to Pathologies of the Brain |
Q36944201 | From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders |
Q47695435 | Gap junction channels as potential targets for the treatment of major depressive disorder |
Q34588846 | Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder |
Q26798929 | Glia in the cytokine-mediated onset of depression: fine tuning the immune response |
Q38738216 | Glial cells as key elements in the pathophysiology and treatment of bipolar disorder. |
Q38512084 | Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease |
Q39141123 | Human astrocytes in the diseased brain. |
Q98157812 | Integrative omics analysis identifies differential biological pathways that are associated with regional grey matter volume changes in major depressive disorder |
Q58769612 | Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression |
Q34413336 | Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders |
Q96172053 | N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cells |
Q21245244 | Neuroinflammation and psychiatric illness |
Q21129480 | Neuroplasticity and the next wave of antidepressant strategies |
Q37213631 | No relative expansion of the number of prefrontal neurons in primate and human evolution |
Q64937747 | Quinolinic Acid and Nuclear Factor Erythroid 2-Related Factor 2 in Depression: Role in Neuroprogression. |
Q41646482 | Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. |
Q45386158 | Reduced serum levels of neuron specific enolase (NSE) in drug-naïve subjects with major depression and bipolar disorder |
Q91012639 | Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice |
Q92403414 | Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms |
Q92914190 | The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders |
Q91640172 | The involvement of astrocytes in early-life adversity induced programming of the brain |
Q38032968 | The role of glia in late-life depression. |